Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density

Robert Eriksson; Brian V. Broberg; Pelle L. Ishoy; Nikolaj Bak; Ulrik B. Andersen; Niklas R. Jorgensen; Filip K. Knop; Bjørn H. Ebdrup

doi:10.3389/fpsyt.2018.00781

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density

Robert Eriksson, Brian V. Broberg, Pelle L. Ishoy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jorgensen, Filip K. Knop, Bjørn H. Ebdrup

4 Citationer (Scopus)

22 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	781
Tidsskrift	Frontiers in Psychiatry
Vol/bind	9
Antal sider	7
ISSN	1664-0640
DOI	https://doi.org/10.3389/fpsyt.2018.00781
Status	Udgivet - 2019

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.3389/fpsyt.2018.00781

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral DensityForlagets udgivne version, 201 KB

Citationsformater

Eriksson, R., Broberg, B. V., Ishoy, P. L., Bak, N., Andersen, U. B., Jorgensen, N. R., Knop, F. K., & Ebdrup, B. H. (2019). Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. Frontiers in Psychiatry, 9, Artikel 781. https://doi.org/10.3389/fpsyt.2018.00781

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. / Eriksson, Robert; Broberg, Brian V.; Ishoy, Pelle L. et al.
I: Frontiers in Psychiatry, Bind 9, 781, 2019.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Eriksson, R, Broberg, BV, Ishoy, PL, Bak, N, Andersen, UB, Jorgensen, NR, Knop, FK & Ebdrup, BH 2019, 'Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density', Frontiers in Psychiatry, bind 9, 781. https://doi.org/10.3389/fpsyt.2018.00781

@article{18be0390446940a3a248f7f01adbe867,

title = "Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density",

keywords = "exenatide, procollagen type I N-terminal propeptide (PINP), C-terminal cross-linking telopeptide of type I collagen (CTX), bone mineral density, randomized controlled trial",

author = "Robert Eriksson and Broberg, {Brian V.} and Ishoy, {Pelle L.} and Nikolaj Bak and Andersen, {Ulrik B.} and Jorgensen, {Niklas R.} and Knop, {Filip K.} and Ebdrup, {Bj{\o}rn H.}",

year = "2019",

doi = "10.3389/fpsyt.2018.00781",

language = "English",

volume = "9",

journal = "Frontiers in Psychiatry",

issn = "1664-0640",

publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density

AU - Eriksson, Robert

AU - Broberg, Brian V.

AU - Ishoy, Pelle L.

AU - Bak, Nikolaj

AU - Andersen, Ulrik B.

AU - Jorgensen, Niklas R.

AU - Knop, Filip K.

AU - Ebdrup, Bjørn H.

PY - 2019

Y1 - 2019

KW - exenatide

KW - procollagen type I N-terminal propeptide (PINP)

KW - C-terminal cross-linking telopeptide of type I collagen (CTX)

KW - bone mineral density

KW - randomized controlled trial

U2 - 10.3389/fpsyt.2018.00781

DO - 10.3389/fpsyt.2018.00781

M3 - Journal article

C2 - 30745885

SN - 1664-0640

VL - 9

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

M1 - 781

ER -

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater